Meiragtx Holdings Plc (MGTX) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Meiragtx Holdings Plc  (NASDAQ: MGTX)


Meiragtx Holdings Plc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Meiragtx Holdings Plc's ROA in the second quarter of 2026?
Meiragtx Holdings Plc achieved a return on average assets (ROA) of 28.86 % in its second quarter of 2026, this is above MGTX's average return on assets of -32.9%.
Meiragtx Holdings Plc assets over the 12 months ending in its second quarter of 2026 are valued at $274 million

ROA has improved compared to -54.13% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 33 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3976, from total ROA ranking in the first quarter of 2026 at 4621.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 102.33 % 109.67 % -9.16 % -28.62 % -15.05 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 79 -121 -114 -169 -158
Return On Assets (TTM) 28.86 % -54.13 % -60.16 % -86 % -73.21 %
MGTX's Total Ranking # 3976 # 4621 # 4255 # 4220 # 4299
Total Assets (TTM) in million 402 251 251 189 199
Seq. Total Assets Change 59.93 % 0.09 % 32.57 % -4.65 % 65.73 %
Seq. Net Income Change - - - - -

MGTX's 5 Years Annual ROA >> Back to MGTX Management Effectiveness >> Compare MGTX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 7
Sector # 34
Overall # 128

Return On Assets Statistics
High Average Low
29.37 %
-32.9 %
-76.51 %
(Jun 30 2026)   (Sep 30 2025)





Financial Statements
Meiragtx Holdings Plc's Assets $ 402 million MGTX's Balance sheet
Meiragtx Holdings Plc's Income $ 161 million Quarterly MGTX's Income Statement
MGTX's Income by Division See MGTX's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change -9.16 % -17.09 % 2.76 % 1.51 % -1.28 %
Total Assets in million 251 277 334 325 320
Y / Y Net Income Change - - - - -
Net Income in million -114 -148 -84 -130 -58
Annual Return On Assets -45.47 % -53.45 % -25.19 % -39.94 % -18.14 %

MGTX's 5 Years Annual ROA >> Back to MGTX Management Effectiveness >> Compare MGTX ROA to its Competitors



More Return On Assets Ratios
MGTX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MGTX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MGTX's Competitors
Subscribers only: Roa for Meiragtx Holdings Plc's Suppliers
Subscribers only: Return On Assets for MGTX's Customers

You may also want to know
MGTX's Roi MGTX's Inventory Turnover Ratio MGTX's Growth Rates MGTX's Dividend Comparisons
MGTX's Profitability Ratios MGTX's Asset Turnover Ratio MGTX's Dividend Growth
MGTX's Roe MGTX's Valuation Ratios MGTX's Financial Strength Ratios MGTX's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Rigel Pharmaceuticals Inc  72.27 %
Actinium Pharmaceuticals Inc  71.73 %
Sanuwave Health Inc   71.60 %
Exelixis Inc   70.51 %
Rallybio Corporation  64.51 %
Oramed Pharmaceuticals Inc  64.18 %
Fortress Biotech Inc   60.88 %
Atlantic Coastal Acquisition Corp Ii  54.09 %
Lensar Inc   47.48 %
Elite Pharmaceuticals Inc   46.11 %
Omeros Corporation  46.05 %
Q32 Bio Inc   45.18 %
Aurinia Pharmaceuticals Inc   44.95 %
Agenus Inc  44.86 %
Earth Science Tech Inc   44.02 %
Liquidia Corporation  36.30 %
Ironwood Pharmaceuticals inc   34.34 %
Idexx Laboratories Inc  33.61 %
Tg Therapeutics Inc   33.59 %
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %

Date modified: 2026-09-12T06:23:21+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.